Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
about
Selective apoptotic cell death effects of oral cancer cells treated with destruxin BCacospongionolide and scalaradial, two marine sesterterpenoids as potent apoptosis-inducing factors in human carcinoma cell linesSaponins isolated from Asparagus induce apoptosis in human hepatoma cell line HepG2 through a mitochondrial-mediated pathway.Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapyInvestigating breast cancer cell behavior using tissue engineering scaffolds.Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cellsAntiproliferative activities of halogenated thieno[3,2-d]pyrimidinesABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL.Delivery of intracellular-acting biologics in pro-apoptotic therapies.N-terminally cleaved Bcl-xL mediates ischemia-induced neuronal deathPersonalized medicine in CLL: current status and future perspectives.Antitumor conjugates with polyamine vectors and their molecular mechanisms.Oligonucleotide delivery in cancer therapy.Nanotechnology in the management of cervical cancer.Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells.2-(Pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl) thiophene induces apoptosis through reactive oxygen species-mediated JNK activation in human colon cancer SW620 cells.Metastatic SW620 colon cancer cells are primed for death when detached and can be sensitized to anoikis by the BH3-mimetic ABT-737.CDK-associated Cullin 1 can promote cell proliferation and inhibit cisplatin-induced apoptosis in the AGS gastric cancer cell line.Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol.Disruption of Myc-Max heterodimerization with improved cell-penetrating analogs of the small molecule 10074-G5.Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine.Structure-based approach to the design of BakBH3 mimetic peptides with increased helical propensity.Quercetin induces apoptosis and enhances 5-FU therapeutic efficacy in hepatocellular carcinoma.
P2860
Q33903806-F4BF8680-FA87-42F6-B238-C25DE4E92E3AQ34234982-FA01F045-DD6A-478E-98F6-54159A113A04Q34372256-8F737A90-30BE-4D8E-9277-178BEC7BC4C2Q35099238-4330AC9D-B44C-46FB-9E3A-9CD11FA71541Q35250316-B16D9DB7-FD49-4249-A122-DC0B4C8ED960Q35416266-842FAEC0-A80A-4207-897C-9393356FF32DQ36047250-FDC00FB5-2085-4CD3-9C5C-CCBB7B86160CQ36523693-1785ED0F-008D-4557-8A2E-ECD31B7E6EE8Q36588920-AD153900-3B92-4270-9D9F-5CD8520D475FQ37390204-D1B051C6-F07B-4FB1-B6D0-A6403121EDEAQ37412148-3BAF24BD-3DD0-4672-B636-08FEBE445DDCQ37773362-7271DE52-8140-42B0-AB39-E820F6F3AB83Q37803214-19AC98C7-1DF4-49E8-9BD7-C2DF31D86520Q38370785-BB03EC22-B4FC-48FF-BD32-A2C45AEAAF20Q38792887-2EB507CA-0084-40E5-952B-A6A7ED605EC2Q38960790-2DD92F5C-FA22-45C4-A5C0-D3214ED22DF7Q39096646-64BA49E1-3DE7-4E89-B0EB-E0839DF1B934Q39212145-0679BAA5-3930-48F1-825D-1467D6A074C5Q39413532-6D8B9AE1-7EC1-4208-BA53-FD2A388B9D22Q42091827-FD82B40D-94AB-4C23-AAE2-A6802D47CB3FQ42117299-F454C1F0-1FBA-4D8B-BC1A-A1F15E455BFFQ45833697-A3A84A3C-747A-4905-8459-442097BEA1EDQ52899086-F3D1E8BC-CA8F-48A2-9944-D1C183033576
P2860
Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
@en
Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
@nl
type
label
Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
@en
Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
@nl
prefLabel
Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
@en
Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
@nl
P1476
Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
@en
P2093
Alan Richardson
Stanley B Kaye
P304
P356
10.2174/1874467210801030244
P577
2008-11-01T00:00:00Z